Zum Hauptinhalt wechseln

Für Chemie, Herstellung und Kontrollen

Für Chemie, Herstellung und Kontrollen

Posters  -  14 May 2024

LC-MS for improving decision making and mitigating risk in process development

Aktuell

Artikel

Articles  —  27 September Sep 2025

eBOOK: mRNA-LNPs for vaccine and gene therapy indications

Read More about eBOOK: mRNA-LNPs for vaccine and gene therapy indications
Articles  —  24 July Jul 2025

Gene therapy in-use and device compatibility studies

Read More about Gene therapy in-use and device compatibility studies
Articles  —  2 July Jul 2025

Analytical procedure development following ICH Q14: An AQbD approach

Read More about Analytical procedure development following ICH Q14: An AQbD approach

Infoblätter

Posters  —  27 September Sep 2023

Evaluating the effect of formulation on the uptake of a Zika virus subunit vaccine candidate by antigen-presenting cells

Read More about Evaluating the effect of formulation on the uptake of a Zika virus subunit vaccine candidate by antigen-presenting cells
Posters  —  27 September Sep 2023

LNP vaccine formulation screening for cellular uptake using BODIPY-labeled lipid nanoparticles

Read More about LNP vaccine formulation screening for cellular uptake using BODIPY-labeled lipid nanoparticles
Posters  —  9 May May 2023

Multi-attribute monitoring with waters_connect™ peptide MAM: A formulation development case study

Read More about Multi-attribute monitoring with waters_connect™ peptide MAM: A formulation development case study

Poster

Posters  —  27 April Apr 2026

Semi-automated liquid handling: Mitigating analyst-to-analyst variability in QC bioassays

Read More about Semi-automated liquid handling: Mitigating analyst-to-analyst variability in QC bioassays
Posters  —  23 March Mar 2026

Semi-automated liquid handling: Mitigating analyst-to-analyst variability in QC bioassays

Read More about Semi-automated liquid handling: Mitigating analyst-to-analyst variability in QC bioassays
Posters  —  27 January Jan 2026

Higher order structure (HOS) analysis of Yersinia pestis virulence factor Caf1 polymerization using carboxyl-group foot-printing

Read More about Higher order structure (HOS) analysis of Yersinia pestis virulence factor Caf1 polymerization using carboxyl-group foot-printing

Videos & Webinare

Umfassende biopharmazeutische analytische Expertise und Objektivität, wenn es darauf ankommt

Wissenschaftler für biopharmazeutische CMC-Dienstleistungen

Verlassen Sie sich auf das umfassende biopharmazeutische Analyse-Know-how von Labcorp Biopharmaceutical Chemistry, Manufacturing and Control (CMC) Services, um Ihren Fortschritt bei der Arzneimittelentwicklung voranzutreiben. Unsere Fachexperten sind versiert in der Charakterisierung, Formulierungsentwicklung und analytischen Entwicklung sowie in der Qualitätskontrolle und arbeiten mit Ihnen zusammen, um Ihre Programme geschickt voranzutreiben und häufige Fallstricke zu vermeiden.

Allan Watkinson, PhD

 Dir, BioPharm Dev Bio, CMC

Anas Tomeh, PhD

 Research and Development Scientist

Caroline Heap, PhD

 Sr Lead Scientist | Supervisory Organization - Harrogate, UK

Colin Guy, PhD

 Senior Manager Assay Development, Method Development & Validation

Hazel Staton

 Lead Scientist, GMP R&D - Harrogate

Henry Fisher, PhD

 Assay Development Scientist, Method Development & Validation

Leonard Bell, PhD

 Lead Assay Development Scientist, Method Development & Validation

Rachel Smith, PhD

 Senior Scientist, CMC, R&D - York, UK

Tobey Gooding

 Quality Control Scientist III, Quality Control

Warren Rowland

 Senior Quality Control Section Manager, Quality Control